NCT01659762View on ClinicalTrials.gov

A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2015

Conditions
Crohn's Disease
Interventions
BIOLOGICAL

autologous mesenchymal stromal cell

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
collaborator

Atlanta Clinical and Translational Science Institute

OTHER

lead

Emory University

OTHER

NCT01659762 - A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease. | Biotech Hunter | Biotech Hunter